WEBINARS

 

Wednesday September 9th, 9AM EST - 1PM EST

Discovering and identifying optimal use of adjuvants

 
Panel members:
 

Dr Wolfgang Leitner, Chief, Innate Immunity Section, Basic Immunology Branch, NIAID, NIH

Dr Derek O'Hagan, Senior Advisor in R&D, GSK Vaccines

Dr Ofer Levy, Director, Precision Vaccines Program, Boston Children’s Hospital & Professor, Harvard Medical School

Dr Jay Evans, President and CEO, Inimmune Corporation & Director, Center for Translational Medicine, University of Montana

Dr Elke S. Bergmann-Leitner, Malaria Vaccine Branch, US Military Malaria Research Program, Walter Reed Army Institute of Research

Dr M. Suresh, John E. Butler Professor of Comparative and Mucosal Immunology, University of Wisconsin-Madison

Tyler Martin, MD, Chairman, President & CEO, Adjuvance Technologies, Inc.

 

SPONSORED BY

 

REGISTER FOR FREE

 

 

Monday September 14th, 11AM EST – 12PM EST

Overcome Vaccine Production Bottlenecks with Real-time Infectivity - When Saving Time Means Saving Lives

 
Speaker:
 
Sean Hart, CEO, LumaCyte
 

SPONSORED BY

LumaCyte
 

REGISTER FOR FREE

 

 

Tuesday September 15th, 10AM EST – 12PM EST

Implementing improved analytical methods to support vaccine quality - Part 1

 

Panel members:

 

Dr Earl Zablackis, Director-Principle Scientist, Sanofi Pasteur 

Dr Francesco Berti, Scientific Director – Analytical/Technical R&D, GSK Vaccines

Dr Dean Smith, Section Head & Senior Scientific Evaluator of Vaccines, Health Canada

Dr Arifa Khan, Principal Investigator/Supervisory Microbiologist in the Division of Viral Products, CBER, FDA

Moderated by Dr Dirk Redlich, VP, Head CMC Development and Clinical Trial Material Manufacturing, Janssen

 

SPONSORED BY

 
 

REGISTER FOR FREE

 

 

Wednesday September 16th, 10AM EST – 12PM EST

Implementing improved analytical methods to support vaccine quality - Part 2

 

Panel members:

 

Dr Maura C. Kibbey, Senior Scientific Fellow, Education & Training, Global Biologics, USP

Dr Sabrina Restrepo, Director, Global Vaccines Technical Operations, Merck

Dr Marta Isabel da Conceição Carreira Germano, Scientific Director Group Head of Product Characterization, Janssen

Dr Jean-Francois Dierick, Global Subject Matter Expert, Analytical Method Validation & Xianzhi Zhou, Bioassay Manager, GSK Vaccines

Dr Mark van Oojj, Scientific Director, PER.C6 technical lead/ Head of Platform innovation and implementation, Janssen

Panel with all speakers (LIVE) Moderated by Dr Dirk Redlich, VP, Head CMC Development and Clinical Trial Material Manufacturing , Janssen

 

SPONSORED BY

 
 

REGISTER FOR FREE

 

 

Friday September 18th, 10AM EST – 12PM EST

Cutting Through the Noise: Market Evolution and Pathways to Access for COVID-19 Vaccines

 

Panel members:

 

Moderator: Richard Hughes , Managing Director, Avalere Health

John Neal , Managing Director, Avalere Health

Nick Diamond , Consultant, Policy Practise, Avalere Health

Angela Shen, ScD, MPH CAPT (Ret) US Public Health Service, Principal, Llama Public Health Consulting LLC

Phyllis Arthur, Vice President, Infectious Diseases And Diagnostics Policy, Biotechnology Innovation Organization (BIO)

 

SPONSORED BY

 

 

REGISTER FOR FREE